Personalized Medicine (Biologics, Small Molecules, Gene
Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) — The “Personalized Medicine: Market Share, and Growth Analysis by Product Type…
Molecular genetics and therapeutic development for GNE myopathy
Yoshioka W, Noguchi S, Mori-Yoshimura M, Nishino I. Advances in understanding of the natural history, mechanism, extra-muscular manifestations…
UH receives $1M grant to advance Usher Syndrome research
The University of Houston has received a two-year, $1.1 million gift from the Cynthia and George Mitchell Foundation…
Breakthrough reveals how viruses efficiently pack genetic material
Researchers at San Diego State University and Michigan State University are shedding new light on how viruses meticulously…
A novel MCMDC2 variant causes meiotic arrest and non-obstructive azoospermia in a consanguineous Chinese family
Cerván-MartÃn M, Castilla JA, Palomino-Morales RJ, Carmona FD. Genetic landscape of nonobstructive azoospermia and new perspectives for the…
Bone Marrow Failure Market Growth Accelerates with Advances in Cell and Gene Therapy
Advancements in Treatment Modalities Therapeutic innovation is reshaping the treatment landscape. The development of targeted therapies, gene therapy,…
CRISPR-Based Gene Editing Market Size to Surpass USD 13.39 Billion by 2034 Driven by Precision Medicine, Therapeutics, and Agricultural Applications
CRISPR-Based Gene Editing Market Size by Product 2023 and 2024 (USD Million) Product 2023 2024 Kits & Reagents…
MYH2-associated myopathy caused by novel compound heterozygous mutations: a case report and literature review
Morales PN, Coons AN, Koopman AJ, Patel S, Chase PB, Parvatiyar MS, et al. Post-translational modifications of vertebrate…
Expect health insurance prices to rise next year, brokers and experts say
Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for…
A Japanese familial spastic paraplegia associated with a missense UBQLN2 variant
Statland JM, Barohn RJ, McVey AL, Katz JS, Dimachkie MM. Patterns of weakness, classification of motor neuron disease,…
Opus Genetics’ OPGx-BEST1 cleared to enter clinic – BioWorld MedTech
Opus Genetics’ OPGx-BEST1 cleared to enter clinic BioWorld MedTechOpus Genetics Announces FDA Clearance of IND Application for Gene Therapy…
Texas Children’s successfully treats AADC deficiency using FDA-approved gene therapy
Texas Children’s is pleased to announce that a three-year-old girl has been successfully treated with the first-ever FDA-approved…